PACS Group (PACS) – Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of PACS Group (NYSE: PACS) in the last few weeks:

• 11/5/2026 – PACS Group had its price target raised by UBS Group from $60.00 to $67.00. They now have a “buy” rating on the stock.
• 11/5/2026 – PACS Group had its “buy” rating reaffirmed by Truist Financial. They now have a $65.00 price target on the stock, up from $62.00.
• 11/5/2026 – PACS Group had its price target raised by Stephens from $60.00 to $64.00. They now have an “overweight” rating on the stock.
• 11/4/2026 – PACS Group was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 10/8/2026 – PACS Group was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.

PACS Group Trading Down 3.8%

NYSE:PACS opened at $48.18 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.80 and a quick ratio of 0.80. The business’s 50-day simple moving average is $45.15 and its 200-day simple moving average is $40.31. PACS Group, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $51.68. The stock has a market capitalization of $7.65 billion, a PE ratio of 27.22, a price-to-earnings-growth ratio of 1.63 and a beta of -0.14.

PACS Group (NYSE:PACS) last announced its earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.58 by $0.05. The business had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. Sell-side analysts expect that PACS Group, Inc. will post 2.05 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Mark Hancock sold 186,696 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the transaction, the director owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. This trade represents a 0.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the completion of the transaction, the chief executive officer directly owned 53,954,101 shares of the company’s stock, valued at approximately $2,710,654,034.24. This trade represents a 0.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,781,666 shares of company stock worth $81,840,913. 70.10% of the stock is owned by corporate insiders.

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.